LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.15 | 21.74 | 2759 | 6167 | 0.4473 | 0.8120 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.15 | 21.74 | 5865 | 6167 | 0.9509 | 0.9877 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.15 | 21.74 | 4380 | 6167 | 0.7102 | 0.9177 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.15 | 21.74 | 5523 | 6167 | 0.8955 | 0.9731 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 80.12 | 21.74 | 3321 | 6211 | 0.5346 | 0.8522 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 80.12 | 21.74 | 5837 | 6211 | 0.9397 | 0.9848 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 80.12 | 21.74 | 2876 | 6211 | 0.4630 | 0.8199 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 80.12 | 21.74 | 6039 | 6211 | 0.9722 | 0.9931 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 80.12 | 21.74 | 4369 | 6211 | 0.7033 | 0.9156 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 80.12 | 21.74 | 5775 | 6211 | 0.9297 | 0.9822 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.09 | 21.74 | 3036 | 6201 | 0.4896 | 0.8323 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.09 | 21.74 | 6031 | 6201 | 0.9725 | 0.9932 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.09 | 21.74 | 2956 | 6201 | 0.4767 | 0.8263 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.09 | 21.74 | 6274 | 6201 | 1.0117 | 1.0029 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.09 | 21.74 | 4305 | 6201 | 0.6942 | 0.9125 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.09 | 21.74 | 5983 | 6201 | 0.9648 | 0.9912 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.06 | 21.74 | 2852 | 6152 | 0.4636 | 0.8199 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.06 | 21.74 | 6173 | 6152 | 1.0034 | 1.0008 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.06 | 21.74 | 2522 | 6152 | 0.4099 | 0.7926 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.06 | 21.74 | 6398 | 6152 | 1.0400 | 1.0096 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.06 | 21.74 | 3899 | 6152 | 0.6338 | 0.8911 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.06 | 21.74 | 6174 | 6152 | 1.0036 | 1.0009 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.03 | 21.74 | 2240 | 6155 | 0.3639 | 0.7666 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.03 | 21.74 | 6403 | 6155 | 1.0402 | 1.0097 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.03 | 21.74 | 2456 | 6155 | 0.3990 | 0.7867 | MN20160310_N01 | H12 |